The association between research and development expenditure and firm performance: testing a life cycle hypothesis
AbstractAlthough prior studies provide evidence that investment in research and development (R&D) expenditure enhances a firm's performance, very little evidence is available on the impact of a firm's life cycle stages on the association between R&D expenditures and firm performance. We classify firms into three-life cycle stages, namely, growth, mature and stagnant, and choose four-life cycle classification variables which are dividends, sales growth, capital expenditure and firm age. Using 769-firm-year observations over a period of 11-years in Australia, we find that the abnormal returns to unexpected expensed R&D amounts are significantly negative. Further, our results suggest that market reaction to expensed R&D is more negatively pronounced during the stagnant phase of a firm's life cycle, suggesting that the market perceives that firms have limited prospects to derive benefits arising out of expensed R&D expenditures. The results suggest that the relationship between performance and investment in R&D is not linear but is moderated by a firm's life cycle which should be taken into account when making policy that is based on stock-based performance.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Bibliographic InfoArticle provided by Inderscience Enterprises Ltd in its journal Int. J. of Accounting, Auditing and Performance Evaluation.
Volume (Year): 7 (2011)
Issue (Month): 4 ()
Contact details of provider:
Web page: http://www.inderscience.com/browse/index.php?journalID=41
research and development; R&D expenditure; firm performance; cumulative abnormal returns; CAR; company life cycle; Australia; stock-based performance.;
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Graham Langley) or (Christopher F. Baum).
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.